These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12831060)
1. Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases. Kim TH; Kim E; Yoon D; Kim J; Rhim TY; Kim SS Angiogenesis; 2002; 5(3):191-201. PubMed ID: 12831060 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human prothrombin kringle-2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression. Kim TH; Ahn S; Kim J; Kim I; Yang MZ; Lee JE; Kim SS Clin Exp Metastasis; 2006; 23(7-8):391-9. PubMed ID: 17187228 [TBL] [Abstract][Full Text] [Related]
4. Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth. Rhim TY; Park CS; Kim E; Kim SS Biochem Biophys Res Commun; 1998 Nov; 252(2):513-6. PubMed ID: 9826562 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization. Hwang HS; Kim DW; Kim SS Biochem J; 2006 Apr; 395(1):165-72. PubMed ID: 16390327 [TBL] [Abstract][Full Text] [Related]
6. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells. Lee TH; Rhim T; Kim SS J Biol Chem; 1998 Oct; 273(44):28805-12. PubMed ID: 9786880 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human prothrombin kringle-2 induces bovine capillary endothelial cell cycle arrest at G0-G1 phase through inhibition of cyclin D1/CDK4 complex: modulation of reactive oxygen species generation and up-regulation of cyclin-dependent kinase inhibitors. Kim TH; Oh S; Kim SS Angiogenesis; 2005; 8(4):307-14. PubMed ID: 16400524 [TBL] [Abstract][Full Text] [Related]
8. p22 is a novel plasminogen fragment with antiangiogenic activity. Kwon M; Yoon CS; Fitzpatrick S; Kassam G; Graham KS; Young MK; Waisman DM Biochemistry; 2001 Nov; 40(44):13246-53. PubMed ID: 11683633 [TBL] [Abstract][Full Text] [Related]
9. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369 [TBL] [Abstract][Full Text] [Related]
11. Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis. Xin L; Xu R; Zhang Q; Li TP; Gan RB Biochem Biophys Res Commun; 2000 Oct; 277(1):186-90. PubMed ID: 11027661 [TBL] [Abstract][Full Text] [Related]
12. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli. You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278 [TBL] [Abstract][Full Text] [Related]
13. A peptide derived from human prothrombin fragment 2 inhibits prothrombinase and angiogenesis. Kim BJ; Koo SY; Kim SS Thromb Res; 2002 Apr; 106(1):81-7. PubMed ID: 12165293 [TBL] [Abstract][Full Text] [Related]
14. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221 [TBL] [Abstract][Full Text] [Related]
15. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331 [TBL] [Abstract][Full Text] [Related]
16. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456 [TBL] [Abstract][Full Text] [Related]
17. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387 [TBL] [Abstract][Full Text] [Related]
18. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity. Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393 [TBL] [Abstract][Full Text] [Related]
19. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863 [TBL] [Abstract][Full Text] [Related]
20. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]